{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-fibrotic", "bile duct ligation", "gallic acid", "liver cirrhosis", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37452479", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1080/00365521.2023.2229929"], "Journal": {"ISSN": "1502-7708", "JournalIssue": {"Volume": "58", "Issue": "12", "PubDate": {"Year": "2023", "Season": "Jul-Dec"}}, "Title": "Scandinavian journal of gastroenterology", "ISOAbbreviation": "Scand J Gastroenterol"}, "ArticleTitle": "Gallic acid improves liver cirrhosis by reducing oxidative stress and fibrogenesis in the liver of rats induced by bile duct ligation.", "Pagination": {"StartPage": "1474", "EndPage": "1483", "MedlinePgn": "1474-1483"}, "Abstract": {"AbstractText": ["Disturbance in the production and excretion of bile acid causes cholestatic liver disease. Liver cirrhosis is a disease that occurs if cholestasis continues. This study evaluated the protective effect of gallic acid (GA) on liver damage caused by biliary cirrhosis. Rats were randomly divided into 4 groups, each with 8 subjects: 1) control, 2) BDL, 3) BDL\u2009+\u2009GA 20, and 4) BDL\u2009+\u2009GA 30. The rats were anesthetized 28\u2009days after the BDL, followed by collecting their blood and excising their liver. Their serum was used to measure liver enzymes, and the liver was used for biochemical analysis, gene expression, and histopathological analysis. Serum levels of liver enzymes, total bilirubin, liver Malondialdehyde level (MDA), expression of inflammatory cytokines and caspase-3, necrosis of hepatocytes, bile duct proliferation, lymphocytic infiltration, and liver fibrosis showed an increase in the BDL group compared to the control group (<i>p</i>\u2009<\u20090.05). In addition, BDL decreased the activity of liver antioxidant enzymes and glutathione (GSH) levels compared to the control group (<i>p</i>\u2009<\u20090.05). The groups receiving GA indicated a decrease in liver enzymes, total bilirubin, MDA, the expression of inflammatory cytokines and caspase-3, and a reduction in liver tissue damage compared to the BDL group (<i>p</i>\u2009<\u20090.05). The level of GSH in the BDL\u2009+\u2009GA 20 group showed a significant increase compared to the BDL group (<i>p</i>\u2009<\u20090.05). Moreover, it was found that GA, with its anti-fibrotic and anti-inflammatory properties, reduces liver damage caused by biliary cirrhosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Razi Herbal Medicines Researches Center, Lorestan University of Medical Sciences, Khorramabad, Iran."}], "LastName": "Jafaripour", "ForeName": "Leila", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran."}], "LastName": "Sohrabi Zadeh", "ForeName": "Behzad", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "General Department of Education, Education Research Institute, Khuzestan, Ahvaz, Iran."}], "LastName": "Jafaripour", "ForeName": "Elham", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Ahmadvand", "ForeName": "Hassan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Asadi-Shekaari", "ForeName": "Majid", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Scand J Gastroenterol", "NlmUniqueID": "0060105", "ISSNLinking": "0036-5521"}, "ChemicalList": [{"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}, {"RegistryNumber": "632XD903SP", "NameOfSubstance": "Gallic Acid"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}, {"RegistryNumber": "RFM9X3LJ49", "NameOfSubstance": "Bilirubin"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Caspase 3"}, {"QualifierName": ["pharmacology", "therapeutic use", "metabolism"], "DescriptorName": "Gallic Acid"}, {"QualifierName": ["etiology"], "DescriptorName": "Liver Cirrhosis, Biliary"}, {"QualifierName": ["pathology"], "DescriptorName": "Liver"}, {"QualifierName": ["etiology", "pathology"], "DescriptorName": "Liver Cirrhosis"}, {"QualifierName": ["pathology"], "DescriptorName": "Cholestasis"}, {"QualifierName": ["surgery", "pathology"], "DescriptorName": "Bile Ducts"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pathology"], "DescriptorName": "Liver Diseases"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Glutathione"}, {"QualifierName": [], "DescriptorName": "Bilirubin"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Ligation"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2023", "Month": "11", "Day": "27", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "15", "Hour": "11", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "15", "Hour": "1", "Minute": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37452479", "10.1080/00365521.2023.2229929"]}}], "PubmedBookArticle": []}